Patents by Inventor John Stuart Andrews

John Stuart Andrews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug combination for the treatment of depression and related disorders comprising mirtazapine
    Patent number: 6835728
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: December 28, 2004
    Assignee: Akzo Nobel N.V.
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward
  • Drug combination for the treatment of depression and related disorders comprising mirtazapine
    Publication number: 20030105083
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Application
    Filed: October 8, 2002
    Publication date: June 5, 2003
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward
  • Use of mirtazapine for treating sleep apneas
    Patent number: 6303595
    Abstract: The compound mirtazapine is found to be effective in treating sleep apneas. Optionally, mirtazapine is combined with an SSRI such as fluoxetin.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: October 16, 2001
    Assignee: Akzo Nobel N.V.
    Inventor: John Stuart Andrews